Overview & Objectives
The ultimate goal of Sydney Catalyst is to
improve the outcomes of those affected by cancer or at risk of
developing it, through discovery, new knowledge and the development
and implementation of more effective cancer treatments, supportive
care and preventative strategies.
To achieve this, we have established a translational cancer
research program built on a broad cross-disciplinary team with
skills in many areas including genomics, cancer biology/molecular
oncology and molecular profiling, biobanking, bioinformatics, drug
development, biostatistics and clinical epidemiology, as well as
strong communication, education and operational strategies to
ensure these diverse teams can work collaboratively and
The major goals and key objectives of Sydney
Goal 1 - Develop and implement a
comprehensive research program across the translational continuum -
T1, T2 and T3.
1.1 Develop and lead world class translational research through
3 flagship programs.
1.2 Support major translational research programs led by Sydney
Catalyst members including CINSW schemes, other large state and
federally funded programs.
1.3 Continue to build core competencies across the full spectrum
of translational research.
1.4 Build capacity in evidence into practice and implementation
research to ensure the timely and efficient translation of evidence
Goal 2 -Facilitate improved professional
development, communication, and collaboration across the
2.1 Build an engaged and active community of Sydney Catalyst
members through a formal communication and collaboration
2.2 Support the professional development, education and training
of our members through a unique program of translational research
2.3 Support early- and mid-career researchers to develop
outstanding careers in translational cancer research.
2.4 Seek and receive feedback from members, collaborators and
other key stakeholders on the success of the program and
opportunities for development and improvement.
Goal 3 - Build capacity in research, improve
competitive advantage in securing other funds.
3.1 Facilitate improved research governance and contractual
arrangements across the consortium.
3.2 Identify and engage key stakeholders, using a range of
specific research projects, activities and communication strategies
to build and maintain effective partnerships.
3.3 Provide research support incl. concept development, tools to
identify collaborators and resources, identification and
incorporation of 'translation into practice' plans.
3.4 Convene and facilitate themed Working Groups (WGs) to
provide an important focus for advocacy of and expertise and
activity in bench to bedside (T1/T2) research and evidence into
practice (T2/T3) research.
Goal 4 - Challenge the traditional, administrative
and institutional barriers between clinicians and researchers to
support a culture of embedding research and evidence in cancer
4.1 Facilitate local and systems change through active
engagement with clinicians and health professionals across a range
of disciplines, plus clinical leads and health services and
managers, using specific projects and activities as exemplars for
facilitating the translation of clinical problems into research
questions and answers.
4.2 Develop and support initiatives to bind researchers and
clinicians in their routine work.
4.3 Assess and describe the extent to which research is and can
be embedded in healthcare.